Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
EPA’s Roundup Safety Decision Based on Industry Data, Despite Independent Researchers’ Warnings November 6, 2015 Irvin Jackson Add Your Comments A new report warns that a recent determination by U.S. environmental regulators that Monsanto’s weed killer Roundup is not an endocrine disruptor appears to be based almost entirely on data provided by industry, and apparently ignores a number of independent studies pointing to evidence that the active ingredient, glyphosate, disrupts the human endocrine system. The medical journal The Intercept published a report on November 3, which examines how the U.S. Environmental Protection Agency (EPA) made it’s decision (PDF) earlier this year that there was no convincing evidence that glyphosate is an endocrine disruptor. The report found that 27 of the 32 studies the EPA used to reach its decision came from industry. Most of the studies were not even publicly available, and had to be obtained by the publication through a Freedom of Information Act request. Monsanto sponsored most of the studies the EPA used to reach its conclusions, according to the report. ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The decision matters, because it means that the EPA will not require additional testing to review the potential adverse health side effects of Roundup on human hormones. It also comes amid increasing concerns about the potential link between Roundup and non-Hodgkin lymphoma. Roundup is one of the most widely used herbicides, which was introduced by Monsanto in the 1970s. However, questions about the safety of the chemical have emerged, after the World Health Organization’s International Agency for Research on Cancer (IARC) issued a warning in March about the potential risk that Roundup and other gylsphosate herbicides may cause cancer. Monsanto has attempted to dismiss the concerns that Roundup is a human carcinogen, maintaining that the IARC’s conclusions were agenda-driven and based on “junk science.” The manufacturer has said it is convening its own independent panel to review the cancer risks of Roundup. Consumer use of Roundup began to skyrocket in the mid 1990s, after Monsanto introduced genetically engineered crops to withstand treatment with Roundup, killing the weeds and not the crops. Genetically modified crops, like corn and soybean, are branded as being “Roundup Ready.” Some weeds have developed resistance to glyphosate, thus forcing farmers to use higher quantities of Roundup. According to this latest report, three of the five independently funded studies found evidence that indicated glyphosate could be an endocrine disruptor. All but one of the industry studies determined the chemical was harmless. The one study that did find a problem indicated that it might cause health problems in rats, but deemed the findings statistically insignificant. However, according to The Intercept, there was a wealth of data inside those industry reports, the same ones that said glyphosate was problem-free, that indicated there were in fact potential hormonal side effects. Some found that exposure decreased the number of viable fetuses and fetal body weight in rats, found evidence of pancreatic inflammation, and pancreatic cancer. All of the industry reports found reasons to dismiss their own findings of potential glyphosate harm. The FDA’s reliance on industry data raises concerns about its planned review of Roundup and glyphosate in the near future to re-examine its potential cancer links. Monsanto has already stated that it discounts the IARC’s findings, and if the pattern holds, Monsanto will be where the EPA gets most of its data on determining for itself whether glyphosate is a carcinogen. In the meantime, Monsanto faces a growing number of Roundup exposure lawsuits filed on behalf of farm workers, landscapers and other agricultural workers who have been diagnosed with non-Hodgkin lymphoma following heavy exposure to the chemical. Tags: Cancer, Chemical, Endocrine Disruptors, Glyphosate, Herbicide, Monsanto, Roundup More Roundup Lawsuit Stories New Study Appears To Confirm Link Between Roundup and Cancer July 7, 2025 U.S. Supreme Court Invites Government To Weigh In on Roundup Cancer Lawsuits July 1, 2025 Roundup Lawsuit Payout of $611M Upheld by Appeals Court May 29, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Depo-Provera Lawsuit Pre-Settlement Funding and Loans Must Be Disclosed Under Court Order (Posted: today) A U.S. District Judge has ordered women involved in Depo-Provera lawsuits to inform him of any third-party pre-settlement loans they take out, as predatory interest rates may force them to reject settlement offers. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (07/02/2025)Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025) Judge Extends Deadlines in PFAS Lawsuits Over Liver Cancer, Thyroid Cancer (Posted: today) A federal judge has extended deadlines for parties involved in firefighting foam lawsuits to complete discovery and expert reports on liver and thyroid cancer injuries. MORE ABOUT: AFFF LAWSUITPFAS Exposure During Pregnancy Linked to High Blood Pressure in Children: Study (06/26/2025)PFAS Drinking Water Lawsuit Filed by 16 Plaintiffs Over Testicular Cancer, Kidney Cancer, Ulcerative Colitis Side Effects (06/23/2025)AFFF Chemicals May Accelerate Spread of Cancer, Reduce Drug Effectiveness: Study (06/13/2025) Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: yesterday) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)
Depo-Provera Lawsuit Pre-Settlement Funding and Loans Must Be Disclosed Under Court Order (Posted: today) A U.S. District Judge has ordered women involved in Depo-Provera lawsuits to inform him of any third-party pre-settlement loans they take out, as predatory interest rates may force them to reject settlement offers. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (07/02/2025)Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)
Judge Extends Deadlines in PFAS Lawsuits Over Liver Cancer, Thyroid Cancer (Posted: today) A federal judge has extended deadlines for parties involved in firefighting foam lawsuits to complete discovery and expert reports on liver and thyroid cancer injuries. MORE ABOUT: AFFF LAWSUITPFAS Exposure During Pregnancy Linked to High Blood Pressure in Children: Study (06/26/2025)PFAS Drinking Water Lawsuit Filed by 16 Plaintiffs Over Testicular Cancer, Kidney Cancer, Ulcerative Colitis Side Effects (06/23/2025)AFFF Chemicals May Accelerate Spread of Cancer, Reduce Drug Effectiveness: Study (06/13/2025)
Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: yesterday) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)